• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-羟色氨酸与唐氏综合征患者的睡眠

5-Hydroxytryptophan and sleep in Down's syndrome.

作者信息

Petre-Quadens O, De Lee C

出版信息

J Neurol Sci. 1975 Nov;26(3):443-53. doi: 10.1016/0022-510x(75)90213-0.

DOI:10.1016/0022-510x(75)90213-0
PMID:171348
Abstract

Polygraphic total night sleep electroencephalographic (EEG), electro-oculographic (EOG) and electromyographic (EMG) recordings have been made in 6 mongoloid infants who received oral 5-HTP for periods extending from 12 to 36 months. The doses were adapted to the infants' age and tolerance level. The oculomotor activity of paradoxical sleep (PS) was selectively analysed. The eye-movement (EM) density was significantly decreased in non-treated mongoloids as compared with that of normal age-related infants. Out of the 5-HTP-treated patients, however, the results in only 2 were within the limits for normal age-related infants. 5-HTP failed to induce any long-term differences in the EM frequencies. In fact, the drug had a short-term effect lasting up to 8 days. An increase in muscle tone and an improvement of motor behaviour were the only long-lasting results.

摘要

对6名接受口服5-羟色氨酸长达12至36个月的蒙古症婴儿进行了多导睡眠脑电图(EEG)、眼电图(EOG)和肌电图(EMG)全夜记录。剂量根据婴儿的年龄和耐受水平进行调整。对异相睡眠(PS)的动眼活动进行了选择性分析。与正常年龄相关的婴儿相比,未经治疗的蒙古症患者的眼动(EM)密度显著降低。然而,在接受5-羟色氨酸治疗的患者中,只有2人的结果在正常年龄相关婴儿的范围内。5-羟色氨酸未能在眼动频率上引起任何长期差异。事实上,该药物有长达8天的短期效应。肌张力增加和运动行为改善是唯一持久的结果。

相似文献

1
5-Hydroxytryptophan and sleep in Down's syndrome.5-羟色氨酸与唐氏综合征患者的睡眠
J Neurol Sci. 1975 Nov;26(3):443-53. doi: 10.1016/0022-510x(75)90213-0.
2
Sleep EEG patterns in a case of Down's syndrome--before and after 5-HTP.唐氏综合征患者在服用5-羟色氨酸前后的睡眠脑电图模式
Electroencephalogr Clin Neurophysiol. 1969 Sep;27(7):686. doi: 10.1016/0013-4694(69)91304-2.
3
5-hydroxytryptophan (5-HTP) in Down's syndrome.
Dev Med Child Neurol. 1971 Jun;13(3):362-72. doi: 10.1111/j.1469-8749.1971.tb03274.x.
4
The use of 5-HTP in the treatment of Down's syndrome.5-羟色氨酸在唐氏综合征治疗中的应用。
Pediatrics. 1974 Aug;54(2):165-8.
5
[Down's syndrome and serotonin].[唐氏综合征与血清素]
Saishin Igaku. 1968 Feb 10;24(2):328-31.
6
The effect of high doses of 5-hydroxytryptophan on a patient with trisomy 21. Clinical, chemical and EEG correlations.高剂量5-羟色氨酸对一名唐氏综合征患者的影响。临床、生化及脑电图相关性研究。
Brain Res. 1968 Nov;11(2):397-411. doi: 10.1016/0006-8993(68)90033-4.
7
Reversal of hypotonia in infants with Down's syndrome by administration of 5-hydroxytryptophan.通过给予5-羟色氨酸逆转唐氏综合征婴儿的肌张力减退。
Lancet. 1967 May 27;1(7500):1130-3. doi: 10.1016/s0140-6736(67)91708-4.
8
Review of drug treatment for Down's syndrome persons.
Am J Ment Defic. 1976 Jan;80(4):388-93.
9
[Therapy with 5-hydroxytryptophan of Down's disease].[唐氏综合征的5-羟色氨酸治疗]
Nord Med. 1969 Jul 31;81(31):952-4.
10
Medicinal treatment for relief of hypotonia in Down's Syndrome.用于缓解唐氏综合征肌张力减退的药物治疗。
Physiotherapy. 1976 Jan;62(1):19-20.

引用本文的文献

1
5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology.5-羟色氨酸(5-HTP):天然存在、分析、生物合成、生物技术、生理学和毒理学。
Int J Mol Sci. 2020 Dec 26;22(1):181. doi: 10.3390/ijms22010181.
2
Sleep measurement and monitoring in children with Down syndrome: a review of the literature, 1960-2010.唐氏综合征儿童的睡眠测量和监测:1960-2010 年文献回顾。
Sleep Med Rev. 2012 Oct;16(5):477-88. doi: 10.1016/j.smrv.2011.10.003. Epub 2012 Mar 10.